Kozhnosys

Kozhnosys is a healthcare technology company dedicated to improving medical diagnostics through non-invasive breath analysis. The company focuses on developing affordable and accessible diagnostic solutions, particularly for early disease detection, with an emphasis on critical illnesses such as breast cancer. Their flagship product, CanScan, is a portable breathalyzer that identifies specific volatile organic compound (VOC) patterns, or "breathprints," linked to diseases. With over 95% sensitivity and specificity, CanScan detects breast cancer at its earliest stages, providing a safer alternative to traditional screening methods by avoiding radiation exposure. The device is user-friendly and designed for diverse settings, enhancing healthcare access and patient comfort. Kozhnosys also develops VOC-based health screening tools that deliver real-time health insights through non-invasive methods. This technology supports early diagnosis and ongoing monitoring of chronic illnesses, equipping individuals and healthcare providers with valuable data to improve health outcomes. The company is led by medical oncologist Dr. Shona Nag, who brings significant expertise in cancer care and innovation.

• Employees 5
• Founded 2015